Patent ID: 6720146
Filing Date: 2004-04-13
Classification: A61K,A61P,C07K,Y10S,Y10T

Abstract:
A method for determining the presence of ovarian cancer in a patient, comprising the steps of:(a) contacting a biological sample obtained from a patient with a selected from the group consisting of: a) about 20 to about 363 contiguous nucleotides of SEQ ID NO:199, b) about 20 to about 1917 contiguous nucleotides of SEQ ID NO:214, and c) complete complements of a) and b); (b) detecting in the sample an amount of an expressed polynucleotide that hybridizes to the probe under moderately stringent conditions; and (c) comparing the amount of expressed polynucleotide that hybridizes to the probe to a predetermined cut-off value, and therefrom determining the presence of ovarian cancer in the patient.